Couverture de Collaborative Psychiatry QuickTakes

Collaborative Psychiatry QuickTakes

Collaborative Psychiatry QuickTakes

De : Collaborative Psychiatry
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce contenu audio
Short, high-yield tips on managing mental health disorder in primary care and other non-psychiatric settings. For more information on managing mental health in primary care, see our website at collaborative-psychiatry.org. To access the printable PDF clinical resources and patient handouts associated with each episode, check out the QuickTake pages at collaborative-psychiatry.org/quicktakes.© 2025 Collaborative Psychiatry Science
Épisodes
  • Stimulant Use Disorder: What Can We Actually Offer?
    Nov 5 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    A patient wants help reducing cocaine or methamphetamine use. Fewer use days, shorter binges, and better daily functioning can be meaningful goals, even when stopping completely feels out of reach. What can we reasonably offer?

    This episode explores bupropion with or without naltrexone, mirtazapine, and topiramate: when each might fit, how co-occurring symptoms and substance use affect the choice, and what to watch for at follow-up. We also discuss contingency management, opioid precautions before naltrexone, and setting realistic expectations for off-label medication trials.

    Visit the episode page for the key clinical takeaways and the downloadable Medications for Stimulant Use Disorder clinical reference, a two-page guide to medication selection, practical dosing, opioid precautions, and follow-up. Keep it nearby when choosing a trial or reviewing whether treatment is helping. The download is available with a free Collaborative Psychiatry account.

    For a related approach to reducing harm while keeping patients engaged, explore Benzodiazepines in the Grey Zone. This case series and clinical toolkit works through complex decisions about ongoing prescribing, co-occurring substance use, and difficult tapers.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Afficher plus Afficher moins
    21 min
  • Antidepressant Augmentation: When One Medication Helps but Not Enough
    Oct 19 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    An antidepressant has made a real difference, but the patient is still struggling. When there is a benefit worth preserving, the next step may be to add treatment for what symptoms remains rather than start over with a different medication. The useful question is: what change are we hoping the add-on will make?

    This episode offers a practical approach to antidepressant augmentation: when it makes sense, how to choose an add-on for a specific goal, and how to tell whether it has earned its place. We discuss bupropion for low energy or SSRI-related sexual side effects, mirtazapine for poor sleep or appetite, and aripiprazole when depression remains disabling. We also address combining antidepressants, mirtazapine dosing, and what to watch for at follow-up.

    Visit the episode page for the key clinical takeaways and the downloadable Antidepressant Augmentation clinical reference—a one-page comparison of bupropion XL, mirtazapine, aripiprazole, brexpiprazole, and quetiapine XR, with practical doses, key cautions, and follow-up checks. The download is available with a free Collaborative Psychiatry account.

    For the broader approach to diagnosis, medication selection, titration, switching, and augmentation, explore the Managing Depression Clinical Framework. It also discusses other augmentation options, including lithium, T3, and modafinil.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Afficher plus Afficher moins
    17 min
  • The Antidepressant Is Helping - But Not Enough
    Sep 27 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    A patient can still say, "I'm depressed," even when an antidepressant has changed something meaningful. Low periods may be shorter, mornings may take less effort, or getting to work may be more reliable. Those changes can be easy to miss if the only question is whether the depression has resolved.

    This episode looks at how to recognize a partial response, check whether the medication has had an adequate trial, and use the response pattern to decide whether to give it more time, optimize the dose, switch antidepressants, or consider augmentation. Side effects, safety, and the patient's priorities may change the usual next step.

    Visit the episode page for the key clinical takeaways and two downloadable resources: Antidepressant Response: Optimize, Switch, or Augment?, a two-page clinical decision tool, and Antidepressant Response Check-In, a worksheet patients can bring to follow-up to describe what has changed. Both downloads are available with a free Collaborative Psychiatry account.

    For a broader approach to diagnosis, medication selection, follow-up, switching, and augmentation, explore the Managing Depression in Primary Care Clinical Framework.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Afficher plus Afficher moins
    15 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment